AI Drug Discovery & Molecular Design

Accelerate pharmaceutical R&D with AI-powered molecular simulation, target identification, toxicity prediction, and clinical trial optimization.

• De novo molecular design with generative AI
• Protein-ligand binding affinity prediction
• ADMET toxicity and pharmacokinetics modeling
• Clinical trial cohort matching and optimization
• Multi-target drug candidate screening

• Reduce drug discovery timelines from 12 to 4 years
• Cut R&D costs by 60% with AI-guided candidate selection
• Predict toxicity before expensive animal studies
• Increase first-in-human trial success rates